Sotorasib Combo Improves Patient-Reported Outcomes in KRAS G12C+ CRC
Written by
Cancer Network
Published
0
comments
0
min
Data suggest that sotorasib plus panitumumab may represent a valuable new treatment option in this KRAS G12C-mutated colorectal cancer population.